Literature DB >> 35895379

The Reasons for Excess Mortality during the COVID-19 Pandemic.

Christopher T Leffler, Sneha Konda.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35895379      PMCID: PMC9294692          DOI: 10.4269/ajtmh.22-0243b

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


× No keyword cloud information.
Dear Sir, We agree with Drs. Mattiuzzi and Lippi that excess mortality during the pandemic is not exactly equivalent with mortality caused by SARS-CoV-2 infection. We noted that excess mortality may result from “Health system overload, delays in patients seeking unrelated healthcare … social changes such as lockdowns … other diseases, war, or environmental factors. Mortality deficits … may result from fewer injuries.” We found that the excess mortality during the COVID-19 pandemic in India, through August 31, 2021, was 198.7 per 100,000 population (range 146.1–263.8 per 100,000). For context, the Hopkins dataset we used reflected COVID-19 mortality of 203.1 per 100,000 population in the United States as of August 31, 2021. So, the excess mortality in India is comparable with the COVID-19 mortality in countries with more robust testing. The survey that Drs. Mattiuzzi and Lippi cited does not demonstrate that delays in seeking healthcare resulted in increased mortality of this magnitude. The survey respondents obviously had not died, and the survey did not ask whether anyone in the family had died as a result of delayed care. The most disruptive lockdowns in India occurred in Spring 2020. However, the bulk of the excess mortality in India occurred in Spring 2021, coincident with the delta-variant COVID-19 wave, and to a lesser degree in Fall 2020. Thus, we believe that the bulk of the excess mortality in India was in fact due to COVID-19 infection.
  3 in total

1.  Preliminary Analysis of Excess Mortality in India During the COVID-19 Pandemic.

Authors:  Christopher T Leffler; Joseph D Lykins V; Saurav Das; Edward Yang; Sneha Konda
Journal:  Am J Trop Med Hyg       Date:  2022-04-04       Impact factor: 3.707

2.  Effects of COVID-19 lockdown phases in India: an atmospheric perspective.

Authors:  Pramod Soni
Journal:  Environ Dev Sustain       Date:  2021-01-06       Impact factor: 3.219

3.  Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020.

Authors:  Mark É Czeisler; Kristy Marynak; Kristie E N Clarke; Zainab Salah; Iju Shakya; JoAnn M Thierry; Nida Ali; Hannah McMillan; Joshua F Wiley; Matthew D Weaver; Charles A Czeisler; Shantha M W Rajaratnam; Mark E Howard
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-11       Impact factor: 17.586

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.